Invesaro

Stocks Comparison

Axe Compute vs HeartSciences: revenue, profit, margins and growth compared

Axe Compute brought in $125.3K of revenue in fiscal 2025, HeartSciences $4.3K in fiscal 2026. Revenue changed by +47.7% at Axe Compute and -0.7% at HeartSciences on the year before, so Axe Compute grew faster. Axe Compute kept -186,053.4% of its revenue as net profit, HeartSciences -211,666.5%. Free cash flow was -$9.9M at Axe Compute and -$7.4M at HeartSciences.

Side by side, latest fiscal year

AGPUHSCS
Fiscal year endedFY2025 (December 31, 2025)FY2026 (April 30, 2026)
Revenue$125.3K$4.3K
Revenue growth+47.7%-0.7%
Net income-$233.1M-$9.1M
Net margin-186,053.4%-211,666.5%
Free cash flow-$9.9M-$7.4M
Free cash flow margin-7,882.9%-172,036.6%
Earnings per share (diluted)-$13.37-$3.48
Cash$10.8M$1.7M
Debtn/an/a
Price to earningsn/an/a
Market value$140.1M$18.4M
Dividend yieldn/an/a
Rank by revenue in sector#615 of 646 · Health care#646 of 646 · Health care

Over the years

Revenue
AGPU FY2018: $1.4MAGPU FY2019: $1.4MAGPU FY2020: $1.3MAGPU FY2021: $1.4MAGPU FY2022: $1.5MAGPU FY2023: $1.6MAGPU FY2024: $84.8KAGPU FY2025: $125.3KHSCS FY2023: $14.4KHSCS FY2023: $5.2KHSCS FY2024: $18.6KHSCS FY2025: $4.4KHSCS FY2026: $4.3KFY18FY19FY20FY21FY22FY23FY24FY25FY26
AGPU $125.3KHSCS $4.3K
Net income
AGPU FY2018: -$10.1MAGPU FY2019: -$19.4MAGPU FY2020: -$25.9MAGPU FY2021: -$19.7MAGPU FY2022: -$25.7MAGPU FY2023: -$14MAGPU FY2024: -$12.7MAGPU FY2025: -$233.1MHSCS FY2023: -$4.8MHSCS FY2023: -$6.4MHSCS FY2024: -$6.6MHSCS FY2025: -$8.8MHSCS FY2026: -$9.1MFY18FY19FY20FY21FY22FY23FY24FY25FY26
AGPU -$233.1MHSCS -$9.1M
Net margin
AGPU FY2018: -714.5%AGPU FY2019: -1,373.7%AGPU FY2020: -2,067.0%AGPU FY2021: -1,383.6%AGPU FY2022: -1,709.6%AGPU FY2023: -859.1%AGPU FY2024: -14,932.3%AGPU FY2025: -186,053.4%HSCS FY2023: -33,592.6%HSCS FY2023: -123,384.3%HSCS FY2024: -35,511.9%HSCS FY2025: -201,499.5%HSCS FY2026: -211,666.5%FY18FY19FY20FY21FY22FY23FY24FY25FY26
AGPU -186,053.4%HSCS -211,666.5%
Revenue growth
AGPU FY2019: -0.0%AGPU FY2020: -11.3%AGPU FY2021: +13.4%AGPU FY2022: +6.0%AGPU FY2023: +8.1%AGPU FY2024: -94.8%AGPU FY2025: +47.7%HSCS FY2023: -64.2%HSCS FY2024: +261.2%HSCS FY2025: -76.6%HSCS FY2026: -0.7%FY19FY20FY21FY22FY23FY24FY25FY26
AGPU +47.7%HSCS -0.7%
Free cash flow
AGPU FY2018: -$5.5MAGPU FY2019: -$8.7MAGPU FY2020: -$12.6MAGPU FY2021: -$13.1MAGPU FY2022: -$12.8MAGPU FY2023: -$13.2MAGPU FY2024: -$10.1MAGPU FY2025: -$9.9MHSCS FY2023: -$3.6MHSCS FY2023: -$5.8MHSCS FY2024: -$6.1MHSCS FY2025: -$7.4MHSCS FY2026: -$7.4MFY18FY19FY20FY21FY22FY23FY24FY25FY26
AGPU -$9.9MHSCS -$7.4M

Fiscal years as each company reports them; the two may end in different months.

Questions about Axe Compute and HeartSciences

Which is bigger by revenue, Axe Compute or HeartSciences?

Axe Compute is bigger by revenue: $125.3K in fiscal 2025, against $4.3K for HeartSciences in fiscal 2026.

Which keeps more of its revenue as profit, Axe Compute or HeartSciences?

Axe Compute had a net margin of -186,053.4% in fiscal 2025; HeartSciences had -211,666.5% in fiscal 2026.

Which grew revenue faster, Axe Compute or HeartSciences?

In their latest fiscal years revenue changed by +47.7% at Axe Compute and -0.7% at HeartSciences.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies